Fri, April 28, 2023
Thu, April 27, 2023
Wed, April 26, 2023

Sean Dodge Reiterated (TDOC) at Buy and Held Target at $35 on, Apr 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-35-on-apr-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Sean Dodge of RBC Capital, Reiterated "Teladoc Health, Inc." (TDOC) at Buy and Held Target at $35 on, Apr 27th, 2023.

Sean has made no other calls on TDOC in the last 4 months.



There are 9 other peers that have a rating on TDOC. Out of the 9 peers that are also analyzing TDOC, 5 agree with Sean's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Garro of "Stephens & Co." Initiated at Hold and Held Target at $25 on, Wednesday, April 12th, 2023
  • Stan Berenshteyn of "Wells Fargo" Maintained at Hold with Decreased Target to $23 on, Monday, March 6th, 2023
  • Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $33 on, Monday, February 27th, 2023
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $27 on, Monday, February 27th, 2023
  • Marc Solecitto of "Barclays" Maintained at Hold with Decreased Target to $28 on, Wednesday, January 18th, 2023


These are the ratings of the 4 analyists that currently disagree with Sean


  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $36 on, Monday, March 6th, 2023
  • Stephanie Davis of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $34 on, Thursday, February 23rd, 2023
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Thursday, February 23rd, 2023
  • Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $37 on, Thursday, January 19th, 2023

Publication Contributing Sources